Hemo Organic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/09/2026 ,inter alia, to consider and approve proposal for raising funds

19th September, 2026 BSE Limited, Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai – 400 001 Sub: Intimation of Board meeting to be held on Wednesday, 23rd September, 2026. Ref: Scrip Code: 524590 | Symbol: HEMORGANIC | ISIN: INE422G01015 Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company will be held on Wednesday, 23rd September, 2026, at the Registered office of the Company to discuss and consider, inter-alia, the following matters: 1. To consider and approve the proposal for raising funds, in one or more tranches by way of issue of Equity Shares and/or Convertible Securities, including Convertible Warrants, for cash or consideration other than cash, including by way of share swap, through preferential allotment, private placement, qualified institutions placement (“QIP”), rights issue, further public issue or any other permissible mode or combination thereof subject to such statutory /regulatory/other approvals as may be required, including the approval of the members, to seek their consent for such fund raising and ancillary actions for such fund raising. 2. To consider and approve any other matter with the permission of the Chair. Further, in terms of the Company’s “Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons” read with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window of the Company will remain closed with effect from business closing hours of 19th September, 2026 till 48 hours after the conclusion of the Board Meeting scheduled to be held on 23rd September, 2026. You are requested to take the above information on record. Thanking you, For Hemo Organic Limited Ayush Dharmendrabhai Jasani Chairman & Additional Director DIN: 09842741